Chinas Pet Market Gains As Domestic Cat Vaccines Challenge Import Monopoly
Feline panleukopenia, calicivirus, and rhinotracheitis vaccines developed by companies like Hisun Animal Health and CAHIC have passed emergency evaluation, marking a breakthrough for domestic feline vaccines and ending the import monopoly. With the expansion of the pet market and policy support, domestic vaccines are expected to gain a significant position in market competition. However, continuous efforts are still needed in product quality, technological innovation, and market promotion to ensure their success and widespread adoption.
